The Siberian hamster (Phodopus sungorus) is a seasonal mammal, exhibiting a suite of physiologically and behaviourally distinct traits dependent on the time of year and governed by changes in perceived day length (photoperiod). These attributes include significant weight loss, reduced food intake, gonadal atrophy and pelage change with short-day photoperiod as in winter. The central mechanisms driving seasonal phenotype change during winter are mediated by a reduced availability of hypothalamic triiodothyronine (T3), although the downstream mechanisms responsible for physiological and behavioural changes are yet to be fully clarified. With access to a running wheel (RW) in short photoperiod, Siberian hamsters that have undergone photoperiod-mediated weight loss over-ride photoperiod-drive for reduced body weight and regain weight similar to a hamster held in long days. These changes occur despite retaining the majority of hypothalamic gene expression profiles appropriate for short-day hamsters. Utilising the somatostatin agonist pasireotide, we recently provided evidence for an involvement of the growth hormone (GH) axis in the seasonal regulation of bodyweight. In the present study, we employed pasireotide to test for the possible involvement of the GH axis in RW-induced body weight regulation. Pasireotide successfully inhibited exercise-stimulated growth in short-day hamsters and this was accompanied by altered hypothalamic gene expression of key GH axis components. Our data provide support for an involvement of the GH axis in the RW response in Siberian hamsters.
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Many species that have evolved for life in a seasonally variable environment have developed physiological strategies to optimise survival. The Siberian hamster is well known for its ability to reduce energy expenditure in winter or short-day photoperiod (SD), exhibiting a suite of physiological adaptations that include reduced body mass and food intake, cessation of reproduction, altered pelage and the ability to employ a controlled hypometabolic state in the form of daily torpor (1) . These responses, which occur naturally in the wild, can be induced in the laboratory by providing a shortened photoperiod length (2) , allowing for the convenient investigation of underlying mechanisms driving these altered physiological processes. This seasonal phenotypic plasticity is underpinned by an alteration of hypothalamic gene expression, primarily of deiodinase enzymes that regulate local thyroid hormone (triiodothyronine; T3) availability (3) . In the Siberian hamster, approximately 50% of SD weight loss comes from fat mass; the remaining is composed of lean, or fat-free mass (4, 5) , and, in male hamsters, fat is mainly lost from abdominal depots (6) . This physiological response occurs in a variety of small mammals and was first observed in the seasonal common shrew by Dehnel and later termed Dehnel's phenomenon (7, 8) .
In the Siberian hamster, Dehnel's phenomenon is reversed by wheel running activity (4, (9) (10) (11) , a phenomenon that has also been observed in the Syrian hamster (Mesocricetus auratus) (12) (13) (14) (15) and gerbils (Meriones unguiculatus) (16) . With access to a running wheel (RW), the Siberian hamster will run for long durations during the normal active phase and, in response, will increase food intake and gain weight (4, 10) . This response occurs to a lesser extent in hamsters adapted to long-day photoperiod (LD; 16 : 8 h light/dark) but is particularly apparent in hamsters adapted to SD (8 : 16 h light/dark) (10, 17) . SD hamsters undertaking RW exercise maintain photoperiod appropriate pelage, whereas torpor is prevented and testicular atrophy is partially reversed. At the same time, hamsters gain body mass so that, over a period of weeks, they increase to a size more appropriate for an LD hamster (4, 9, 11) . This increase in body mass involves both lean and fat tissue (4, 11) , accompanied by increased overall body length, bone length and mineral content (10, 11) , and thus is indicative of somatic growth. Despite attaining LD metabolic physiology, SD exercised hamsters largely retain hypothalamic gene expression profiles of SD sedentary hamsters, with only evidence of a partial reversal of the photoperiod mediated reduction in Pomc gene expression and a slower temporal increase in arcuate nucleus (ARC), somatostatin (Srif) mRNA (8) .
Somatostatin is an inhibitory hormone that is expressed widely in the central nervous system and is an integral component of the growth hormone (GH) axis. The majority of SRIF projections from the hypothalamus to the median eminence are from neurones in the periventricular nucleus (PeVN), which play the main role in the regulation of pituitary GH secretion (18, 19) . To positively regulate GH secretion, growth hormone-releasing hormone (GHRH) is produced in the ventromedial hypothalamus and ARC, with the latter comprising those neurones primarily projecting to the median eminence to reach the somatotrophs of the anterior pituitary via the hypophyseal portal system (20) .
Pasireotide (also called SOM230) is a somatostatin analogue that was developed to treat GH-secreting pituitary tumours in acromegaly (21) . Pasireotide acts with high affinity at four of the five known somatostatin G-protein coupled receptor subtypes (SSTR 1,2,3 , 5 ), with a particularly high affinity for SSTR 5 (22, 23) . Pasireotide mimics the action of somatostatin, inhibiting the secretion of pituitary GH in human and rodent tissue in vitro (24) , as well as GH and insulin-like growth factor (IGF)-1 secretion in vivo, which in turn is accompanied by impaired body mass gain in rodents (25, 26) . We have previously shown that, after 7 weeks of administration to LD hamsters, pasireotide led to significant weight loss, accompanied by a decrease in circulating IGF-1. However, SD hamsters administered with pasireotide did not lose further weight but, when subsequently switched back to LD, pasireotide significantly inhibited weight regain stimulated by LD photoperiod. In addition, pasireotide altered hypothalamic expression of GH axis genes, including Srif in the PeVN and Ghrh in the ARC, and also suppressed a rise in circulating IGF-1, suggesting a key role for the GH axis in the regulation of seasonal body mass (27) . In the Syrian hamster, the reversal of photoperiod-induced physiology by exercise is accompanied by growth and an increase in the pulsatile secretion of several pituitary hormones, including GH (28) . Together with the aforementioned study, we hypothesised that the GH axis might also be involved in the RW-stimulated weight gain demonstrated in the Siberian hamster. Therefore, we established an experiment aiming to mirror our previous study, with pasireotide being administered in a long-acting release form (LAR; 28 days) to SD acclimated hamsters that were given access to a RW, instead of manipulating the photoperiod.
Materials and methods

Animal and tissue collection
All animal experiments and general husbandry were conducted in accordance with the German Animal Welfare Act, and approved by the Lower Saxony State Office for Consumer Protection and Food Safety (license no. 12/1023). All experiments were performed using adult male Siberian hamsters from a colony maintained at the University of Veterinary Medicine, Hannover. Hamsters were bred under natural photoperiod at a latitude of 52°N under ambient temperatures, before being transferred to an artificial LD (16 : 8 h light/dark) after weaning. Food (hamster breeding diet, Altromin 7014; Altromin GmbH, Lage, Germany) and water were available ad lib. throughout, supplemented by a weekly slice of apple and, during the experiments, the hamsters were singly housed. Overhead lighting was provided by fluorescent tubes (Lumilux LF11; Osram, Munich, Germany), resulting in a light intensity of approximately 200-350 lux at cage level. During the dark phase, illumination was limited to dim red light of < 5 lux (15 W, Darkroom Red; Osram). For hamsters provided with a RW (inner diameter 14.5 cm), wheel revolutions were registered and stored at 6-min intervals. For comparison, mean daily distance run per hamster, as calculated over the 49 days of the experiment, was compared. In the pasireotide experiment, further sub-analyses were carried out, with daily running distance compared over the course of the experiment. In addition, to investigate whether the behavioural pattern differed over the course of the dark (active) phase, wheel revolutions in 2-h bins were compared, taking the mean wheel revolutions during each bin for each hamster over the 49 days of the experiment. At the end of the experiments, to determine any acute effects of exercise, nonfasted hamsters were killed by a CO 2 overdose followed by cervical dislocation in the dark (active) phase between zeitgeber time (ZT) 12 and 13, where ZT 0 and ZT8 corresponds to the time of lights on and off, respectively. This timing was chosen so that we could take into account potential changes in circulating hormone levels as a result of RW activity. The brain and trunk blood (from which serum was prepared) were collected and stored at À70°C before use. Testes and liver were dissected and immediately weighed. In the pasireotide experiment, these were returned to carcasses, which were stored at À70°C and later thawed for body composition analysis.
Pasireotide RW experiment
Thirty adult male Siberian hamsters were initially acclimated to SD (8 : 16 h light/dark) for 10 weeks (69-72 days) before they received an s.c. dose of pasireotide LAR (Novartis, Basel, Switzerland; 160 mg/kg based on weight on day of administration) or vehicle only. On the day of administration, hamsters were further split into RW and sedentary groups, of which one vehicle and one pasireotide group received a RW (RW-Vehicle, RW-Pasireotide, both n = 7) and the remaining two groups did not (Sedentary-Vehicle, SedentaryPasireotide, both n = 8). Pasireotide and vehicle treatment was repeated 28 days following the first administration. Body mass was measured from day 2 onwards following pasireotide or vehicle treatment at 4-day intervals, and the change in body mass from the start of pasireotide or vehicle administration was calculated and compared. The initial ambient temperature of 22 AE 1°C was lowered to 20 AE 1°C on day 20 to better facilitate the expression of torpor, as reported elsewhere (29) . Hamsters were killed, as described above, after 49 days (7 weeks) of treatment and/or RW access.
Body composition of dissected hamsters (with brain removed) was determined by nuclear magnetic resonance imaging (MRI) (Echo MRI TM Whole Body Composition Analyser; Echo Medical Systems, Houston, TX, USA). Previously frozen decapitated bodies were doubly sealed in plastic bags, and then disinfected and warmed to 37°C in a water bath before measurement. Three measurements per carcass were taken, and the mean of these measurements was accepted. Data are compared directly and as a ratio of lean : fat mass. Serum glucose was determined using an ACCU-CHEK glucose monitor and test strips (Aviva, Roche, Basel, Switzerland). Enzymelinked immunosorbent assays (ELISAs) were performed on thawed serum in accordance with the manufacturers' instructions. Serum insulin concentration was measured using a rat insulin ELISA kit (Mercodia, Uppsala, Sweden; catalogue number 10-1250-01), with intra-assay coefficients of variations (CVs) of 6.93% and 6.35%, and an inter-assay CV of 6.65%. One RW-Vehicle sample was excluded because of a very high %CV between technical replicates, reducing this group to a sample size of six.
12-week RW experiment
Food intake and hypothalamic Ghrh mRNA expression was investigated in a 12-week RW experiment (4). Briefly, 48 adult male Siberian hamsters were acclimated to either LD or SD, as described above, for 2 weeks before given access to a RW (LD-RW, SD-RW; both n = 10) or not (LD-C, n = 10; SD-C, n = 8). The hamsters were killed as described above, after 84 days (12 weeks), following RW introduction. Body mass and RW revolutions were measured during the course of the experiment and terminal organ mass of liver and testes was recorded. Because of the loss of one LD-RW slide during preparation, the Ghrh in situ hybridisation experiment was reduced to a sample size of nine for this group. Because of excessive crumbling of the food, food intake data were excluded for several hamsters, reducing sample sizes; SD-RW (n = 4), SD-Sedentary (n = 5), LD-RW (n = 10) and LD-Sedentary (n = 9).
Open flow respirometry experiments
Sedentary hamsters were monitored for a period of 2 or 3 days between days 13 and 20 of the experiment, by open flow respirometry, carried out in their home cages (dimensions 24.5 9 15 9 15 cm; volume of approximately 5.5 l). VO 2 and VCO 2 were measured with a FOXBOX field gas analyser (Sable Systems, Las Vegas, NV, USA) at a flow rate of 35-40 L/h. Measurements were taken every 6 min, for five hamsters per session, and were adjusted according to an air reference channel. The body mass specific metabolic rate and respiratory quotient (RQ) were calculated, taking the bodyweight as the mean from the two closest weighing dates (4 days apart).
Riboprobe synthesis
Riboprobes complementary to DNA sequence fragments were generated from Siberian hamster, mouse or rat brain cDNA by a reverse transcriptasepolymerase chain reaction (PCR) (as described previously) (3, 27, (30) (31) (32) . Templates were generated by PCR amplification of the insert from plasmid DNA with M13 forward and reverse primers located 5 0 upstream to polymerase transcription sites in host vectors. Approximately 100 ng of PCR product was used in an in vitro transcription reaction with T7, T3 or SP6 polymerases as appropriate in the presence of 35 S-uridine 5-triphosphate (Perkin Elmer, Beaconsfield, UK) for radioactive in situ hybridisation.
In situ hybridisation
Coronal hypothalamic sections were cryosectioned at 14 lm and mounted on poly-L-lysine coated slides (ThermoScientific, Rockford, IL, USA). Radiolabelled in situ hybridisation was carried out as described previously (33) . Briefly, slides were fixed in 4% paraformaldehyde-0.1 M phosphate buffer, acetylated in 0.25% acetic anhydride-0.1 M triethanolamine, pH 8. Radioactive probes (approximately 10 6 counts per minute per slide) were applied to the slides in 70 ll hybridisation buffer containing 0.3 M NaCl, 10 mM Tris-HCl (pH 8), 1 mM ethylenediaminetetraacetic acid, 0.05% tRNA, 10 mM dithiothreitol, 0.02% ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin and 10% dextran sulphate. Hybridisation was performed overnight (approximately 16 h) at 58°C. The following day, slides were washed in 4 9 saline sodium citrate (SSC) (1 9 SSC is 0.15 M NaCl, 15 mM sodium citrate), treated with ribonuclease A (20 lg/ll) at 37°C and washed in SSC to a stringency of 9 0.1 at 60°C. Dehydrated slides were exposed to Biomax MR film (Kodak, Rochester, NY, USA) for 16 h to 14 days as appropriate.
Image analysis
Autoradiographic films were scanned at 600 dpi to a computer running Image Pro Plus, version 6.8 or version 7.0 (Media Cybernetics, Marlow, UK). Integrated optical density of mRNA expression was obtained in reference to a 14 C microscale and measured in two to five sections per slide for each probe as appropriate, and the accumulated count (arbitrary units) was compared. For presentation purposes, integrated optical density is expressed relative to the sedentary-vehicle or LD-C group, whose value is defined as 1.
Statistical analysis
Data are expressed as the mean AE SEM. Analysis was carried out using MINI-TAB, version 15.0 (Minitab Inc., State College, PA, USA) or PRISM, version 7.0 (GraphPad Software Inc., San Diego, CA, USA). The statistical tests used were conducted using two-way ANOVA (general linear model) with Tukey's post-hoc tests or two-sample t-tests unless stated. P < 0.05 was considered statistically significant. Data not conforming to assumptions of an ANOVA were transformed by log 10 or the square root, and statistics were performed on transformed data (log 10 : serum glucose and insulin data; square root: Ghrh in situ hybridisation data). When data could not be transformed to fit assumptions of the parametric test, Kruskall-Wallis and/or Mann-Whitney tests were performed, with such instances being indicated in the text as appropriate. RW time course data were compared by two-way repeated measures ANOVA followed by Sidak's multiple comparison tests for differences between pasireotide and vehicle data. Correlations between distance travelled and change in body mass were investigated by linear regression. For the change in body mass data, two-way ANOVAS were carried out at each time point, with pasireotide and RW access as factors.
Results
Effect of pasireotide on RW activity-stimulated weight gain, body composition and organ mass Representative actograms are shown in Fig. 1(A) , where the RW activity is double plotted by aligning two consecutive days horizontally and each 24 h is plotted twice (34) , with the full 49 days being shown. Pasireotide treatment did not significantly alter the daily distance run by RW hamsters (Vehicle: 24 458 AE 3945 revolutions, 11.14 AE 1.80 km; pasireotide: 32 947 AE 4520 revolutions, 15.01 AE 1.93 km; P = 0.185) (Fig. 1B) . RW hamsters can be expected to decrease daily wheel running activity over time (10) and, despite a brief drop in activity following the second injection for vehicle hamsters, pasireotide did not alter daily wheel running activity over the course of the experiment, with only an overall effect of time (F 48,624 = 2.038, P < 0.001); however, there were no significant effects in post-hoc analyses (Fig. 1C) . To determine whether pasireotide altered the pattern of wheel running behaviour, mean revolutions per 2 h of the dark phase from the 49 experimental days were compared. There was a significant time effect (F 7,91 = 30.31, P < 0.001), with the greater amount of wheel running occurring in the first 10 h of the dark phase, although no overall significant pasireotide effect was detected. Despite a significant interaction (F 7,91 = 2.722, P = 0.013), vehicle and pasireotide RW activity did not significantly differ at any individual 2-h timepoint (Fig. 1D) . Very little wheel running activity occurred during the light phase, and this did not differ with pasireotide (RW-Vehicle: 1.93 AE 0.56 revolutions, RW-Pasireotide: 1.56 AE 0.65 revolutions).
As expected, RW activity caused weight gain (day 49: F 1,26 = 72.38, P < 0.001) ( Fig. 2A) and the increase in body mass for RW-Vehicle hamsters reached significance compared to all others after only 10 days. Pasireotide attenuated RW-induced weight gain (day 49: F 1,26 = 13.58, P = 0.001), with RW-pasireotide hamsters reaching significant weight gain compared to sedentary counterparts by day 34, and differing from all other groups by day 46. The RW-stimulated weight gain was attenuated by pasireotide, as demonstrated by a significant interaction between these factors (day 49: F 1,26 = 6.05, P = 0.021). No correlation was found between the cumulative distance run over the course of the experiment and change in body mass for either pasireotide-or vehicle-treated hamsters (r 2 = 0.004, P = 0.894; r 2 = 0.182, P = 0.292, respectively) (Fig. 2B) . Furthermore, we determined whether pasireotide might directly alter energy expenditure using open flow respirometry. In sedentary animals, metabolic rate and respiratory quotient did not differ in pasireotide compared to vehicle-treated animals, measured overall, or in either the light or dark phase (see Supporting information, Fig. S1 and Table S1 ). Overall, lean mass of dissected carcasses was significantly increased by RW activity (F 1,26 = 35.78, P < 0.001) and this was suppressed by pasireotide treatment (F 1,26 = 13.94, P = 0.001). There was a significant interaction between factors (F 1,26 = 15.43, P = 0.001), with the RW-vehicle hamsters having a greater lean mass compared to all other treatment combinations (P < 0.001 all comparisons) (Fig. 2C) . Fat mass was only raised by RW activity (F 1,26 = 7.25, P = 0.012) (Fig. 2D) . Because body composition is a relative measure, and because final body mass overall differed dramatically between groups, the ratio of lean-to-fat mass in dissected carcasses was compared. RW hamsters were found to have a small but significantly greater proportion of fat mass overall (Fig. 2E) .
Paired testes mass was significantly increased by RW activity (Kruskall-Wallis test; P < 0.001) but not altered by pasireotide (Kruskall-Wallis test; P = 0.852) and, within RW and sedentary groups, there were no significant effects of pasireotide (Fig. 2F) . Liver mass was used as an indicator of internal organ mass and was significantly increased by RW activity (F 1,26 = 23.74, P < 0.001) (Fig. 2G) , with the effect of pasireotide and interaction between treatments both approaching significance (F 1,26 = 2.94, P = 0.098 and F 1,26 = 3.32, P = 0.080, respectively) (Fig. 2G) . In post-hoc analyses, RW-Vehicle hamsters had significantly greater liver mass than sedentary counterparts (P < 0.001) but, compared to RW-Pasireotide, this difference did not reach significance (P = 0.098). Interestingly, when liver mass was compared as a proportion of body mass, the trend for a pasireotide effect was abolished and only the RW effect remained (F 
Effects of RW activity on serum glucose and insulin concentrations
Terminal (nonfasted) glucose concentrations did not differ between any of the treatment groups (Fig. 3A) ; however, serum insulin was significantly raised in RW hamsters (F 1,25 = 4.42, P = 0.046) and this was independent of pasireotide treatment (Fig. 3B) .
Effect of RW activity and pasireotide hypothalamic mRNA expression
Two key genes in the regulation of photoperiod regulated seasonal phenotype change are those encoding for deiodinase enzymes types II and III (Dio2 and Dio3), which regulate the central availability of active thyroid hormone. In accordance with previous studies (4, 27) , when measured by in situ hybridisation, expression of neither Dio2, nor Dio3 differed with RW activity or pasireotide treatment (Fig. 4A,   B ). Because RW-stimulated weight gain in the Siberian hamster is accompanied by increased food intake (4), the expression of two appetite regulating peptides Pomc and Npy was measured in the ARC. Pomc expression was raised by RW activity independent of pasireotide (F 1,26 = 13.05, P = 0.001) (Fig. 4C ) and this was also the case for Npy expression (F 1,26 = 5.40, P = 0.029) (Fig. 4D) .
To determine whether the observed growth effects may be mediated by an alteration of the central growth hormone axis or by systemic feedback to this axis, hypothalamic expression of Srif in the ARC and PeVN, as well as Ghrh and Gh-r in the ARC, was measured. Arcuate nucleus Srif expression was not altered by RW activity or pasireotide, although a decrease with RW activity approached significance (F 1,26 = 3.54, P = 0.071) (Fig. 4E) . Srif expression in the PeVN was significantly increased with RW activity (F 1,26 = 14.93, P = 0.001) and decreased by pasireotide (F 1,26 = 8.63 P = 0.007) (Fig. 4F) . Expression of Ghrh in the ARC was increased only by RW activity (F 1,26 = 5.44 P = 0.028) (Fig. 4G) . Similarly, Gh-r expression in the ARC was unaltered by pasireotide and significantly increased overall in RW hamsters (F 1,26 = 9.33, P = 0.005) (Fig. 4H) .
Effect of RW on Ghrh expression and food intake in LD and SD hamsters
In a second RW experiment, hamsters exposed to LD or SD for a period of 2 weeks before 12 weeks of RW access, body weight was significantly decreased for the SD-Sedentary hamsters compared to all others by day 35 (P ≤ 0.05). At the end of the experiment, there were significant effects on body mass with both photoperiod and RW activity, with interaction (Photoperiod: F 1,34 = 16.46, P < 0.001; RW Activity: F 1,34 = 33.23, P < 0.001; Interaction: F 1,34 = 5.263, P = 0.028) (Fig. 5A) . For the RW hamsters, photoperiod did not affect the mean distance run (Fig. 5B,C) . As described previously (4), food intake increased for RW hamsters and with LD photoperiod (Photoperiod: F 1,24 = 5.15, P = 0.033; RW Activity: F 1,24 = 50.71, P < 0.001; Interaction: F 1,24 = 0.09, P = 0.764) (see Supporting information, Fig. S2 ). As expected, paired testes mass was significantly reduced in SD hamsters, with no overall effect of RW activity (Kruskall-Wallis test; Photoperiod: H = 27.08, P < 0.001; RW Activity: P = 0.279). However, in pairwise comparisons, both SD-Sedentary and SD-RW hamsters had significantly different paired testes mass compared to all other groups (Mann-Whitney test; P < 0.001, all comparisons), with the SD-RW hamsters having a mid-range mass compared to the SDSedentary and LD hamsters (Fig. 5D) . RW access significantly increased liver mass, with interaction between RW access and photoperiod (Photoperiod: F 1,34 = 2.19, P = 0.148; RW Activity: F 1,34 = 22.82, P < 0.001; Interaction: F 1,34 = 6.10, P = 0.019), with SD-C having a lower liver mass compared to other groups (versus LD-C P = 0.049; versus SD-RW, P < 0.001; versus LD-RW P < 0.001) (Fig. 5E) . Liver mass as a function of body mass did not significantly differ between groups (LD-RW: 46.29 AE 1.50 mg/g; LD-C 45.74 AE 1.65 mg/g; SD-RW: 49.83 AE 3.01 mg/g; SD-C: 44.53 AE 0.63 mg/g).
Expression of ARC Ghrh was significantly raised by RW overall, with a trend for an effect of photoperiod (RW Activity: F 1,33 = 8.18, P = 0.007; Photoperiod: F 1,33 = 3.32, P = 0.078; Interaction: F 1,33 = 0.85, P = 0.362) (Fig. 5F ).
Discussion
The present study aimed to provide evidence to support the hypothesis that the GH axis is involved in the exercise-induced growth response of the Siberian hamster by disrupting the hypothesised stimulation of this axis with the somatostatin analogue pasireotide, as well as by measuring the expression of key GH axis components in the hypothalamus. Pasireotide treatment significantly retarded the body weight increase resulting from access to a RW. Furthermore, access to a RW increased the expression of Srif in the PeVN, indicative of increased feedback to the inhibitory arm of the GH axis, and increased Ghrh expression in the ARC, indicative of increased stimulatory drive to the GH axis. In addition, pasireotide reduced RW-induced Srif expression in the PeVN, indicative of a reduction in GH feedback to the hypothalamus. Because pasireotide is not expected to cross the blood-brain barrier and reduces circulating IGF-1 (25) (26) (27) , the most likely explanations for pasireotide retardation of RW-induced growth are inhibition of GH secretion from the pituitary or inhibition of IGF-1 secretion from the liver, although, as discussed below, other mechanisms may be involved.
The RW response phenomenon may have evolved in this species to take advantage of favourable conditions such as a mild winter or an early spring to reproduce early and maximise offspring number and survival. Wheel running is not a natural behaviour but can represent a natural drive to be active. Indeed, RWs placed in the wild are taken advantage of by a surprising variety of species (35) and it may be a self-rewarding behaviour. The hamsters in the present study ran for comparable distances compared to that reported previously (11) and any trend for reduced mean daily distance run in vehicle hamsters did not reach significance. A temporary and nonsignificant decline in daily distance run by vehicle hamsters following the second administration may account for this apparent trend. As expected for animals housed in SD (36) , further sub-analysis of daily RW activity over the dark period demonstrated the peak of activity in the first of half of the night for all RW hamsters, independent of pasireotide. Therefore, we conclude that RW behaviour was largely unaltered by administration of the drug.
In exercising SD hamsters, weight gain was retarded by pasireotide, with overall lean mass being similar to sedentary counterparts, in contrast to the vehicle-treated RW hamsters. However, weight gain was not completely inhibited by pasireotide. A contribution to weight gain comes from fat mass, which increased with RW activity and did not differ between vehicle and pasireotide treatments. Fig. 4 . Running wheel (RW) stimulated increased gene expression of appetite regulating peptides and growth hormone (GH) axis components, whereas pasireotide only altered expression of periventricular nucleus (PeVN) Srif. Relative mRNA expression of Dio2 (A), Dio3 (B), Pomc (C), Npy (D) and Srif (E) in the arcuate nucleus (ARC), Srif in the (F), and Ghrh (G) and Gh-r (H) in the ARC. *P < 0.05, **P < 0.01, ***P < 0.001. NS, nonsignificant difference. RW groups, both n = 7; sedentary groups, both n = 8. Data are expressed as the mean AE SEM.
Although we found no direct effect of pasireotide on metabolic energy expenditure in sedentary hamsters, it might be argued that a trend for increase in RW activity lead to increased energy expenditure and therefore the diversion of energy from growth. However, this explanation is unlikely because a change in body mass did not correlate with the total distance run. Furthermore, fat mass would be the first source of additional energy mobilised for an increased energy expenditure (37) , and this was similar in all RW hamsters. In the absence of altered energy expenditure, the retarded growth of RW-Pasireotide hamsters might be explained by a reduction in energy intake. One key component of the weight gain experienced by exercising hamsters is increased food intake (4,10,11). We did not measure food intake in the present pasireotide experiment but, clearly, energy intake was sufficient to sustain a similar increase in fat mass in vehicle-and pasireotidetreated hamsters. A lower food intake in pasireotide-treated hamsters would likely occur because of a lower basal metabolic rate as a result of less lean tissue and less energy required to sustain RW-induced muscle accretion and organ growth (38) . This would also be consistent with a reduced orexigenic drive from the GH axis in the brain where GH has been shown to stimulate neuropeptide Y (NPY) neurones, and increase both Npy and Agrp expression (39) (40) (41) .
Food intake can be stimulated and suppressed by appetite regulating neuropeptides expressed in the hypothalamus, and pro-oipomelanocortin (POMC) and NPY are both implicated in appetite control (42) . In our previous study, RW activity was accompanied by an increase in Pomc but no alteration of Npy expression (4) . In the present study, in addition to an increase in Pomc, an increase in Npy expression was also observed. Increased Pomc expression may not necessarily equate to an increased anorexigenic drive because this may depend on the impact of RW activity on downstream processing enzymes that are photoperiodically regulated in a manner to increase anorexic a-MSH production from POMC precursor peptide in SD (43) . However, the discrepancy between these two findings for Npy may lie in the time of sampling because hamsters in the present study were killed during the dark RW active phase when an energy deficit as a result of activity will be greater compared to our previous study in which hamsters were killed during the early light phase when they were not exercising (4). Testicular atrophy was partially retarded in RW hamsters, with no significant effect of pasireotide treatment, suggesting that RW activity had a broad stimulation of neuroendocrine axes. This is similar to a stimulatory effect of RW activity in Syrian hamsters where exercise has been shown to inhibit or reverse photoperiodinduced reduction in prolactin, follicle-stimulating hormone, lueteinising hormone and testosterone, and to reverse reproductive quiescence (44, 45) . Notably, RW-stimulated growth was first observed in the Siberian hamster in castrated male animals (9) and so growth is unlikely to be driven by testosterone produced by the partially recrudesced testes of RW hamsters. Additionally, exerciseinduced growth has been demonstrated in both male and female Syrian hamsters (45) and Siberian hamsters (11) .
In line with previous work (4), the insulin concentration was increased in the serum of RW hamsters, although serum glucose levels did not differ. Any subtle differences in serum glucose might have been masked by the nonfasted state of the hamsters at death. Although the photoperiodic difference in circulating insulin in male Siberian hamsters is well established (4,32), i.p. glucose tolerance tests have revealed no photoperiod differences in glucose clearance for Siberian hamsters (46) . A chronic difference in circulating insulin can be considered indicative of a more obese and generally insulin resistant state, as described for LD hamsters with regard to central insulin signalling (47) . Insulin has a lipogenic activity in Siberian hamster adipocytes (48) ; therefore, a greater concentration of insulin in the serum of RW hamsters may provide a mechanism for the increase and maintenance of fat deposition similar to a LD hamster, in addition to any insulin driven increase in lean mass (49) . The lack of an effect of pasireotide on circulating insulin concentrations supports this interpretation because fat mass was also unaffected.
Alterations in the balance of the central thyroid hormone system are essential for driving seasonal phenotype change in the Siberian hamster (3, 50) . However, as reported previously for RW (4) and pasireotide-treated hamsters (27) , there were no measurable effects on Dio2 and Dio3 expression, indicating action downstream of the integration of the photoperiodic cue.
Gh-r expression remained unaltered in the ARC by pasireotide; however, there was a stimulatory effect of wheel running on the expression of this receptor mRNA. This may have allowed for increased sensitivity to circulating GH, and suggests that tachyphylaxis of this receptor was not a problem with the hypothesised increase in circulating GH. Unfortunately, there was insufficient remaining tissue to compare the photoperiodic expression of GH-R and so it remains to be determined whether there is photoperiodic regulation of this receptor.
In the present study, the effect of wheel running to stimulate increased ARC Ghrh expression was evident in both experiments, as well as in both LD and SD hamsters. Although we previously found that pasireotide significantly increased Ghrh expression in sedentary hamsters independent of photoperiod, the effect of pasireotide on Ghrh expression did not appear to be additive to the RW effect. Wheel running activity has been shown to suppress the SD-stimulated increase in ARC Srif expression, an effect that appears to depend on the length of time that the hamsters had access to a RW and/or the length of time in SD photoperiod (4). Although not quite achieving significance, the present data demonstrated a trend to suppression by RW activity consistent with the previous study, although pasireotide did not alter ARC Srif expression. This indicates that pasireotide does not affect the photoperiodic drive on ARC Srif expression.
As described previously (27) , the expression of Srif in the PeVN was suppressed by pasireotide. Together with increased Ghrh expression in the ARC by RW activity, the findings are consistent with altered feedback of the GH axis to these neurons. Although we cannot definitively conclude the primary driver of growth caused by RW activity is GH, there is evidence supporting the notion that GH underpins this mechanism; (i) the robust increase in pulsatile circulating GH in Syrian hamsters caused by RW activity (28, 51) ; (ii) the persistence of RW-induced growth in castrated hamsters (9); (iii) the known stimulatory effect of GH and suppressive effect of pasireotide on circulating IGF-1 levels in the Siberian hamster (27) ; and (iv) the suppressive effect of pasireotide on RW and LD photoperiod-induced growth. However, because of insufficient serum, we were unable to confirm this definitively based on measurement of circulating IGF-1. Thus, any additional mechanism of inducing somatic growth may still be possible, such as a contribution from increased circulating insulin (49), although evidence from Syrian hamsters suggests that insulin is less likely to contribute to RW-induced somatic growth (52) .
The seasonally adaptive physiology of the Siberian hamster has traditionally been studied as a tool with the aim of understanding the mechanisms for the regulation of appetite, body mass and metabolism. The exercise response that occurs in this species may be counterintuitive when considering that, in general, exercise is known to have health-promoting effects in human physiology across several different parameters. However, even with respect to human physiology, on an individual level, there can be substantial variability in beneficial effects, or even detrimental effects of exercise on specific health parameters (53) (54) (55) (56) that are related to compensatory eating (57) . Considering the current worldwide levels of reported obesity and being overweight, with the main treatments being a reduction in energy intake and increased energy expenditure, it is important to understand how, in certain individuals, specific exercise regimes or treatments might be beneficial to counteract any poor exercise response. We propose that the Siberian hamster exercise response can be considered as a model for a poor exercise response in humans, as typified by the increased serum insulin concentration, weight gain and no reduction in fat mass. Therefore, understanding what drives these physiological changes in the hamster could inform human medicine. 
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